Xerox Holdings Corporation Profile Avatar - Palmy Investing

Xerox Holdings Corporation

Xerox Holdings Corporation, a workplace technology company, designs, develops, and sells document management systems and solutions in the United States, Europe, Canada, and internationally. It offers workplace solutions, including desktop monochrome, and…

Information Technology Services
US, Norwalk [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 260.98 125.02 34.63
Graham Fair Price 34.53 20.72 15.40
PEG 40.50 -0.05 0.04
Price/Book 3.82 0.85 0.82
Price/Cash Flow 316.41 -24.78 5.95
Prices/Earnings 49.81 -4.88 -9.72
Price/Sales 14.91 1.47 1.28
Price/FCF 316.41 -24.78 5.95
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -15.80 0.28 0.33
Operating Margin -76.77 -0.01 0.05
ROA -96.08 -0.01 < 0.005
ROE -0.02 -0.04 -106.85
ROIC < 0.005 < 0.005 -78.01
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.10 -0.04 130.24
Dividends QOQ < 0.005 0.08 743.97
EBIT QOQ 0.37 -1.20 228.06
EPS QOQ -2.62 -0.94 64.28
FCF QOQ 2.38 -1.23 -48.20
Revenue QOQ 0.07 -0.15 117.84
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 50.29 61.05 21.40
Days Sales Outstanding (DSO) 90.56 101.62 12.22
Inventory Turnover 1.79 1.47 -17.63
Debt/Capitalization 0.55 0.58 6.91
Quick Ratio 0.85 1.00 17.65
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 22.36 20.92 -6.47
Cash 4.79 6.01 25.61
Capex -0.08 -0.08 0.69
Free Cash Flow 3.08 -0.72 -76.68
Revenue 14.34 12.12 -15.49
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.14 1.37 20.12
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 19.39 72.50 273.87
Naive Interpretation Member
06 - Financial Health · Weak
End of XRX's Analysis
CIK: 1770450 CUSIP: 98421M106 ISIN: US98421M1062 LEI: - UEI: -
Secondary Listings
XRX has no secondary listings inside our databases.